Average New Yorker Sits 7 Hours a Day

They may live in the “City That Never Sleeps,” but most New Yorkers still sit around a lot — an average of seven hours every day, a new study shows. That estimate may be low, the study authors added, because the data was largely based on what people remembered or admitted to doing.

SOURCE: Hospital Administration News – Read entire story here.

Bigger Share of Deaths Worldwide Now Due to Cancer Title: Bigger Share of Deaths Worldwide Now Due to CancerCategory: Health NewsCreated: 5/28/2015 12:00:00 AMLast Editorial Review: 5/29/2015 12:00:00 AM...
Carbon monoxide sends 17 employees to hospital Police believe an air conditioner released carbon monoxide into a Hauppauge business Wednesday afternoon, sending 17 employees to the hospital. According to the Suffolk County Police Department, a female employee at Liqui-Mark on Davids Drive had complained of a headache and nausea....
How Many People Have Enrolled So Far in Obamacare’s Second Open Enrollment? Undoubtedly I will hear that question many times in the coming weeks. The answer is that this enrollment process is so screwed up we will have no earthly idea how many new people have enrolled and how many 2014 enrollees remained on the program until at least April 2015. Let me try to illustrate. Let's say George is now enrolled in Obamacare. He is happy to have subsidized and guaranteed...
Peregrine Pharmaceuticals Enters Into Research Collaboration to… Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company focused on advancing bavituximab, a novel immuno-oncology agent in Phase III development for the treatment of lung cancer, today announced that the company has entered into a sponsored research agreement with Memorial Sloan Kettering Cancer Center to explore the potential of Peregrine's proprietary phosphatidylserine -targeting antibody platform. The goal of the research is to identify effective treatment combinations based on Peregrine's PS-targeting agents, including Peregrine's lead clinical agent bavituximab, with other checkpoint inhibitors or immune stimulating agents that will further guide the bavituximab clinical development program....
Hospital Closures Had No Measurable Impact On Local Hospitalization Rates Or Mortality Rates, 2003-11 [Access To Care] The Affordable Care Act (ACA) set in motion payment changes that could put pressure on hospital finances and lead some hospitals to close. Understanding the impact of closures on patient care and outcomes is critically important. We identified 195 hospital closures in the United States between 2003 and 2011. We found no significant difference between the change in annual mortality rates for patients living in hospital service areas (HSAs) that experienced one or more closures and the change in rates in matched HSAs without a closure (5.5 percent to 5.2 percent versus 5.4 percent to 5.4 percent, respectively). Nor was...